Related references
Note: Only part of the references are listed.α-synuclein-lanthanide metal ions interaction: binding sites, conformation and fibrillation
Jia Bai et al.
BMC BIOPHYSICS (2016)
α-Synuclein aggregation, seeding and inhibition by scyllo-inositol
Tarek Ibrahim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)
Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity
Huy T. Lam et al.
BIOCHEMISTRY (2016)
Inhibition effects of tanshinone on the aggregation of alpha-synuclein
Kaige Ji et al.
FOOD & FUNCTION (2016)
Understanding Caffeine's Role in Attenuating the Toxicity of α-Synuclein Aggregates: Implications for Risk of Parkinson's Disease
Jay Kardani et al.
ACS CHEMICAL NEUROSCIENCE (2015)
Contact between the 1 and 2 Segments of -Synuclein that Inhibits Amyloid Formation
Hamed Shaykhalishahi et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)
Anle138b and related compounds are aggregation specific fluorescence markers and reveal high affinity binding to ot-synuclein aggregates
Andreas A. Deeg et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2015)
Fibril Breaking Accelerates α-Synuclein Fibrillization
Volodymyr V. Shvadchak et al.
JOURNAL OF PHYSICAL CHEMISTRY B (2015)
α-Synuclein strains cause distinct synucleinopathies after local and systemic administration
W. Peelaerts et al.
NATURE (2015)
Unveiling transient protein-protein interactions that modulate inhibition of alpha-synuclein aggregation by beta-synuclein, a pre-synaptic protein that co-localizes with alpha-synuclein
Maria K. Janowska et al.
SCIENTIFIC REPORTS (2015)
Structure based aggregation studies reveal the presence of helix-rich intermediate during alpha-Synuclein aggregation
Dhiman Ghosh et al.
SCIENTIFIC REPORTS (2015)
Flavone Derivatives as Inhibitors of Insulin Amyloid-Like Fibril Formation
Ricardas Malisauskas et al.
PLOS ONE (2015)
Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein
Nuzhat Ahsan et al.
SCIENTIFIC REPORTS (2015)
The Role of Stable α-Synuclein Oligomers in the Molecular Events Underlying Amyloid Formation
Nikolai Lorenzen et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Dopamine-induced α-synuclein oligomers show self- and cross-propagation properties
Matthew S. Planchard et al.
PROTEIN SCIENCE (2014)
Modeling of chemical inhibition from amyloid protein aggregation kinetics
Jose Antonio Vazquez
BMC PHARMACOLOGY & TOXICOLOGY (2014)
In Vitro Study of α-Synuclein Protofibrils by Cryo-EM Suggests a Cu2+-Dependent Aggregation Pathway
Hangyu Zhang et al.
BIOPHYSICAL JOURNAL (2013)
The genetics and neuropathology of Parkinson's disease
Henry Houlden et al.
ACTA NEUROPATHOLOGICA (2012)
Toxic prefibrillar α-synuclein amyloid oligomers adopt a distinctive antiparallel β-sheet structure
Maria Soledad Celej et al.
BIOCHEMICAL JOURNAL (2012)
Protein aggregation: Mechanisms and functional consequences
Gaetano Invernizzi et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
Kelvin C. Luk et al.
SCIENCE (2012)
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Christian Hansen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Tanshinone IIA attenuates neuronal damage and the impairment of long-term potentiation induced by hydrogen peroxide
Wei Wang et al.
JOURNAL OF ETHNOPHARMACOLOGY (2011)
In vivo demonstration that α-synuclein oligomers are toxic
Beate Winner et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Strategies to increase the reproducibility of protein fibrillization in plate reader assays
Lise Giehm et al.
ANALYTICAL BIOCHEMISTRY (2010)
Baicalein reduces E46K α-synuclein aggregation in vitro and protects cells against E46K α-synuclein toxicity in cell models of familiar Parkinsonism
Mali Jiang et al.
JOURNAL OF NEUROCHEMISTRY (2010)
In Vitro Formation of Amyloid from α-Synuclein Is Dominated by Reactions at Hydrophobic Interfaces
Jeremy Pronchik et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
Pre-fibrillar α-synuclein variants with impaired β-structure increase neurotoxicity in Parkinson's disease models
Damla Pinar Karpinar et al.
EMBO JOURNAL (2009)
Fitting neurological protein aggregation kinetic data via a 2-step, Minimal/Ockham's Razor model: The Finke-Watzky mechanism of nucleation followed by autocatalytic surface growt
Aimee M. Morris et al.
BIOCHEMISTRY (2008)
Impact of Tyr to Ala mutations on α-synuclein fibrillation and structural properties
Natasa Poklar Ulrih et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2008)
Relationships between the sequence of α-synuclein and its membrane affinity, fibrillization propensity, and yeast toxicity
Michael J. Volles et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Alpha-synuclein and neurodegenerative diseases
M Goedert
NATURE REVIEWS NEUROSCIENCE (2001)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Fibrils formed in vitro from α-synuclein and two mutant forms linked to Parkinson's disease are typical amyloid
KA Conway et al.
BIOCHEMISTRY (2000)
Acceleration of oligomerization, not fibrillization, is a shared property of both α-synuclein mutations linked to early-onset Parkinson's disease:: Implications for pathogenesis and therapy
KA Conway et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
